Hengrui Pharma Seeks Up to $1.3 Billion in Hong Kong Listing

Jiangsu Hengrui Pharmaceuticals offers about 225 million shares at a price range of HK$41.45-HK$44.05 apiece in Hong Kong listing, according to an exchange filing.

• Company set to raise as much as HK$9.9 billion ($1.3 billion): Bloomberg calculation
• Trading is expected to begin May 23
• Morgan Stanley, Citi and Huatai International are joint sponsors
• NOTE: Earlier this month, Hengrui Pharma Begins Gauging Investor Interest for HK Listing

(Adds details.)

To contact the reporter on this story:
Alfred Liu in Hong Kong at aliu226@bloomberg.net

To contact the editors responsible for this story:
Meg Shen at mshen145@bloomberg.net

Dominic Lau

© 2025 Bloomberg ...